Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I, Open-Label, Multicentre, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of A Single Intravenous PPMX-T003 in Polycythemia Vera

NCT05074550 is registered in ClinicalTrials.gov with Perseus Proteomics Inc. as lead sponsor.

NCT NCT05074550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05074550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I, Open-Label, Multicentre, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of A Single Intravenous PPMX-T003 in Polycythemia Vera
Lead sponsor
Perseus Proteomics Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
August 24, 2022
Completion date
March 31, 2024
Enrollment
6 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

polycythemia vera